{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:50:45Z","timestamp":1791996645726,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH074"],"award-info":[{"award-number":["ZR2023QH074"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024MH202"],"award-info":[{"award-number":["ZR2024MH202"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.116922","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T21:52:54Z","timestamp":1780005174000},"page":"116922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fexofenadine promotes bone formation and inhibits bone resorption via dual targeting of cPLA2 and Smad2"],"prefix":"10.1016","volume":"184","author":[{"given":"Kaiwen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianli","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hecheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10514","key":"10.1016\/j.intimp.2026.116922_bb0005","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0140-6736(25)01385-6","article-title":"Osteoporosis","volume":"406","author":"Ye","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2026.116922_bb0010","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC202401160","article-title":"Osteoporosis","volume":"177","author":"Ensrud","year":"2024","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.intimp.2026.116922_bb0015","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jama.2025.6003","article-title":"Osteoporosis: a review","volume":"334","author":"Morin","year":"2025","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.intimp.2026.116922_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41584-024-01094-9","article-title":"Evidence-based guideline for the management of osteoporosis in men","volume":"20","author":"Fuggle","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116922_bb0025","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","article-title":"Global, regional, and national burden of bone fractures in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"2","year":"2021","journal-title":"Lancet Healthy Longev."},{"issue":"10","key":"10.1016\/j.intimp.2026.116922_bb0030","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00198-009-0920-3","article-title":"Excess mortality following hip fracture: a systematic epidemiological review","volume":"20","author":"Abrahamsen","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.intimp.2026.116922_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108168","article-title":"Advances in pathogenesis and therapeutic strategies for osteoporosis","volume":"237","author":"Song","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2026.116922_bb0040","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41580-020-00279-w","article-title":"Mechanisms of bone development and repair","volume":"21","author":"Salhotra","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116922_bb0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/med.22081","article-title":"Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis","volume":"45","author":"Yao","year":"2025","journal-title":"Med. Res. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2026.116922_bb0050","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301508RRR","article-title":"Exercise and osteoimmunology in bone remodeling","volume":"38","author":"Zhao","year":"2024","journal-title":"FASEB J."},{"issue":"21","key":"10.1016\/j.intimp.2026.116922_bb0055","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","article-title":"Postmenopausal Osteoporosis","volume":"389","author":"Walker","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.116922_bb0060","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.mcna.2020.06.004","article-title":"Osteoporosis in older adults","volume":"104","author":"Johnston","year":"2020","journal-title":"Med. Clin. North Am."},{"issue":"9","key":"10.1016\/j.intimp.2026.116922_bb0065","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41574-023-00866-9","article-title":"Long-term and sequential treatment for osteoporosis","volume":"19","author":"Foessl","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116922_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.eprac.2024.01.014","article-title":"Treatment sequence for osteoporosis","volume":"30","author":"Cosman","year":"2024","journal-title":"Endocr. Pract."},{"issue":"10","key":"10.1016\/j.intimp.2026.116922_bb0075","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos. Int."},{"issue":"10","key":"10.1016\/j.intimp.2026.116922_bb0080","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jama.2024.0530","article-title":"Allergic rhinitis: a review","volume":"331","author":"Bernstein","year":"2024","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.intimp.2026.116922_bb0085","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2019-215543","article-title":"Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis","volume":"78","author":"Liu","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116922_bb0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41420-025-02754-9","article-title":"Fexofenadine protects against osteoarthritis by targeting Smad2 and STAT1 to enhance anabolism and binding cPLA2 to inhibit catabolism","volume":"11","author":"Liu","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2026.116922_bb0095","article-title":"Fexofenadine protects against intervertebral disc degeneration through TNF signaling","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"20","key":"10.1016\/j.intimp.2026.116922_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011155","article-title":"Cytosolic phospholipase A2 is required for fexofenadine\u2019s therapeutic effects against inflammatory bowel disease in mice","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.intimp.2026.116922_bb0105","first-page":"7224","article-title":"Effect of GGCX on the differentiation function of osteoporosis bone marrow mesenchymal stem cells through regulating TGFbeta\/smad signaling pathway","volume":"23","author":"Wang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.116922_bb0110","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/jbmr.4800","article-title":"Higenamine promotes osteogenesis via IQGAP1\/SMAD4 signaling pathway and prevents age- and estrogen-dependent bone loss in mice","volume":"38","author":"Dong","year":"2023","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.intimp.2026.116922_bb0115","first-page":"206","article-title":"A multifunctional neuromodulation platform utilizing Schwann cell-derived exosomes orchestrates bone microenvironment via immunomodulation, angiogenesis and osteogenesis","volume":"23","author":"Hao","year":"2023","journal-title":"Bioact. Mater."},{"issue":"10329","key":"10.1016\/j.intimp.2026.116922_bb0120","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","article-title":"Drug therapy for osteoporosis in older adults","volume":"399","author":"Reid","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.intimp.2026.116922_bb0125","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJMc2314624","article-title":"Postmenopausal Osteoporosis","volume":"390","author":"Silverstein","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.intimp.2026.116922_bb0130","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20030015","article-title":"An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with inflammation","volume":"197","author":"Miyaura","year":"2003","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116922_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.plefa.2013.12.009","article-title":"Cytosolic phospholipase A2 and eicosanoids modulate life, death and function of human osteoclasts in vitro","volume":"90","author":"Allard-Chamard","year":"2014","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"5","key":"10.1016\/j.intimp.2026.116922_bb0140","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022202","article-title":"TGF-beta family signaling in mesenchymal differentiation","volume":"10","author":"Grafe","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.intimp.2026.116922_bb0145","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/boneres.2015.5","article-title":"TGF-beta\/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation","volume":"3","author":"Rahman","year":"2015","journal-title":"Bone Res"},{"issue":"2","key":"10.1016\/j.intimp.2026.116922_bb0150","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7150\/ijbs.2929","article-title":"TGF-beta and BMP signaling in osteoblast differentiation and bone formation","volume":"8","author":"Chen","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2026.116922_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110852","article-title":"Ellagic acid promotes osteoblasts differentiation via activating SMAD2\/3 pathway and alleviates bone mass loss in OVX mice","volume":"388","author":"Dong","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.intimp.2026.116922_bb0160","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s42003-023-05635-y","article-title":"Atsttrin regulates osteoblastogenesis and osteoclastogenesis through the TNFR pathway","volume":"6","author":"Liu","year":"2023","journal-title":"Commun Biol"},{"issue":"12","key":"10.1016\/j.intimp.2026.116922_bb0165","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41418-025-01543-2","article-title":"GLUL mediates FOXO3 O-GlcNAcylation to regulate the osteogenic differentiation of BMSCs and senile osteoporosis","volume":"32","author":"Zhang","year":"2025","journal-title":"Cell Death Differ"},{"issue":"10","key":"10.1016\/j.intimp.2026.116922_bb0170","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.tibs.2020.05.006","article-title":"Detecting protein-small molecule interactions using limited proteolysis-mass spectrometry (LiP-MS)","volume":"45","author":"Pepelnjak","year":"2020","journal-title":"Trends Biochem. Sci."},{"issue":"51","key":"10.1016\/j.intimp.2026.116922_bb0175","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6141","key":"10.1016\/j.intimp.2026.116922_bb0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.intimp.2026.116922_bb0185","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/annrheumdis-2021-221380","article-title":"Digoxin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritis","volume":"81","author":"Wang","year":"2022","journal-title":"Ann. Rheum. Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600768X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600768X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:32:13Z","timestamp":1791995533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600768X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S156757692600768X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116922","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fexofenadine promotes bone formation and inhibits bone resorption via dual targeting of cPLA2 and Smad2","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116922"}}